As with real estate, oftentimes cancer care and prevention are all about location, location, location. Presenters will discuss the challenges of cancer care delivery for underserved communities in both rural and urban settings. 
Panelists: Julia White, MD, FACR, FASTRO, The University of Kansas Cancer Center; Kathie-Ann Joseph, MD, MPH, FACS, NYU Grossman School of Medicine/NYU Langone Health; and Gary Doolittle, MD, Masonic Cancer Alliance at the University of Kansas School of Medicine

Acute care imposes a significant financial burden on patients and cancer centers. Presenters will explore oncology urgent care centers and unravel the financial intricacies, innovative staffing models, and secrets to success that define these critical health care institutions. This webinar will offer invaluable insights into the evolving landscape of oncology care and strategies for delivering high-quality, patient-centered services in urgent care settings. 
Moderator: Theresa L. Werner, MD, Huntsman Cancer Institute at the University of Utah
Presenters: William Dunson, MD, Huntsman Cancer Institute at the University of Utah; Kinsey Wimmer, MS, PA-C, University of Colorado Cancer Center; Elizabeth Jewell, MD, MHSc, FACOG, FACS, Memorial Sloan Kettering Cancer Center; and David Brauer, MD, MPHS, Masonic Cancer Center, University of Minnesota

Presenters explored unique and often ignored sources of stress for health care professionals that lead to burnout and what institutions, teams, and individuals are doing to support one another. 
Presenters: Quan Ly, MD, FACS, Fred & Pamela Buffett Cancer Center; Sarah Richards, MD, FACP, University of Nebraska Medical Center and Nebraska Medicine; and Steven Wengel, MD, University of Nebraska Medical Center

Survivorship care should be included as a standard of care for all cancer survivors. This presentation reviewed the core aspects of a survivorship program and considerations to make it sustainable.
Moderator: Julie M. Vose, MD, MBA, University of Nebraska Medical Center
Presenters: Laura Tenner, MD, MPH, and Rachael Schmidt, APRN-NP, University of Nebraska Medical Center

Presenters described new advances in artificial intelligence (AI) and machine learning and its impact on cancer care and research. Panelists provided background and shared the potential applications for research and discovery while highlighting the impact on clinical care and patient outcomes.
Moderator: Christopher Lieu, MD, University of Colorado Cancer Center
Presenter: Sean Davis, MD, PhD, University of Colorado Anschutz School of Medicine

A moderated discussion with colleagues in medical, radiation, and surgical oncology about social media and how it can best be harnessed to promote individuals, teams, and the war on cancer. Panelists engaged in an honest discussion about mistakes made and how to learn from them and shared a practical dos and don’ts of Twitter.
Moderator: Julie Ann Sosa, MD, MA, FACS, MAMSE, FSSO, UCSF Helen Diller Family Comprehensive Cancer Center
Presenters: Tatiana Prowell, MD, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University and U.S. Food and Drug Administration; Fumiko Chino, MD, Memorial Sloan Kettering Cancer Center; and Syed Ahmad, MD, University of Cincinnati Medical Center

This webinar provided a practical discussion of paths to developing a career in clinical investigation in cancer research. Presenters who achieved success in launching clinical research early in their careers provided examples of challenges and solutions they encountered along the way. The associate director for education and training at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Dr. Stephen Freedland, also provided early career and transition advice.
Moderator: Karen Reckamp, MD, MS, Cedars-Sinai Cancer
Presenters: Stephen Freedland, MD; Arsen Osipov, MD; and Jun Gong, MD, Cedars-Sinai Cancer

Moderated by Carrie Lee, MD, MPH, this webinar will cover the clinical pharmacist (CP) training and supervision requirements along with roles and responsibilities.

Presenters Maurice Alexander, PharmD, BCOP, CPP; Kaitlyn Buhlinger, PharmD, BCOP; and Kevin Chen, PharmD, MS, will discuss how the CP role can be beneficial with regards to medication adherence, safety, and quality of care. They will also address how to effectively integrate a CP into the clinic workflow, including both paired (with MD) and independent patient visits. Several case examples will be included to illustrate the value of a CP.

The webinar examined the impact of the COVID-19 pandemic on telemedicine.

Telehealth is a critical component of cancer care and all the more vital in the wake of the COVID-19 pandemic. As patient access to telemedicine improves, a range of new challenges arise, from physician licensing issues to geographic restrictions to lack of broadband access in rural areas.

Presenter Charles Ryan, MD, will discuss how the pandemic has impacted the use of telemedicine as well as how telemedicine can be expanded in the future while maintaining patient safety and quality of care. Dr. Ryan is director of the Division of Hematology, Oncology and Transplantation at Masonic Cancer Center, University of Minnesota.

This webinar addressed the challenges associated with maintaining a clinical research practice at an academic cancer center, including navigating salary structures in academia (or lack thereof), defining various areas of academic research, and proposing metrics for measuring clinical research activities.

Presenter: Claire Verschraegen, MS, MD, FACP, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute

The webinar—the first in a two-part series—was presented by Marie Wood, MD, and Wendy McKinnon, MS, on models of testing for pancreatic, breast, ovarian, and prostate cancers. Dr. Wood is the founder and principal investigator of the High-Risk Breast Program (HRBP) at the University of Vermont Cancer Center, a professor of medicine at the University of Vermont and The University of Vermont Medical Center, and a medical oncologist at the University of Vermont Cancer Center. McKinnon is a cancer genetics counselor at the University of Vermont Cancer Center and a clinical assistant professor at the Larner College of Medicine, University of Vermont. Through case studies and guidelines for high-risk individuals, the presenters shared recommendations for genetic testing in patients and their family members. Indications for genetic testing include cancer type and pathology in patients with cancer, family history, and ethnicity. Males with breast cancer, individuals with metastatic prostate or pancreatic cancer, and individuals of Ashkenazi Jewish heritage are all good candidates for genetic testing, due to their increased risk for certain cancers and the survival benefit afforded by early detection.

The webinar—the second in a two-part series—was presented by Joanne Jeter, MD, oncologist and associate professor of medicine, and Heather Hampel, MS, LGC, associate director of the division of human genetics, from The Ohio State University Comprehensive Cancer Center, James Cancer Hospital & Solove Research Institute highlighting models of testing for colon and hematologic cancers and genetic counseling. 

Moderated by Andrew E. Chapman, DO, FACP, chief of cancer services at the Sidney Kimmel Cancer Center at Jefferson Health (SKCC) and member of the PCLI steering committee, the webinar will address strategies for developing and applying a telemedicine approach to oncology. Dr. Chapman will be joined by his SKCC colleagues, Adam Binder, MD, and Ana María López, MD, MPH, MACP. Dr. Binder will focus on the background and importance of telemedicine. Dr. López will follow with specific approaches and considerations for oncology telemedicine. They will close their presentation with future directions and a question and answer period.

Facilitated by Ruben A. Mesa, MD, FACP, director of UT Health San Antonio MD Anderson Cancer Center, the webinar addressed topics including barriers to trial enrollment that may disproportionately impact Latino patients and strategies to facilitate clinical trial participation among diverse populations. 

The webinar was hosted by AACI with Craig A. Bunnell, MD, MPH, MBA, chief medical officer at Dana-Farber Cancer Institute at Harvard Medical School and PCLI steering committee member introducing guest presenter, David Jackman, MD, senior physician in the thoracic oncology program at Dana-Farber Cancer Institute at Harvard Medical School. Dr. Jackman’s clinical research efforts have focused on targeted therapies in lung cancer and mesothelioma, as well as the clinical impact of predictive biomarkers for such therapies. He also serves as the Medical Director for the Dana-Farber Clinical Pathways program, a web-based, oncology decision-support platform powered by content that is fully customized and curated by Dana-Farber’s world class oncology faculty. 

This webinar focused on Multidisciplinary Cancer Care with emphasis on the following topics:  

• The role of a clinical oncology pathways program within academic medicine
• Stakeholders and Support: managing a pathways effort
• Data collection and analysis – lessons to be learned

The webinar was hosted by AACI with Martha Mims, MD, section chief, hematology/oncology and professor of medicine at the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine and PCLI steering committee member introducing guest presenter, Brandon G. Smaglo, MD FACP, medical director of the section of hematology/oncology and assistant professor at the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine. Dr. Smaglo’s clinical and research focuses are in the management of gastrointestinal cancers, and he has particular interest in the identification and clinical exploration of tumor biomarkers as a guide to optimal treatment selection.

This webinar focused on Multidisciplinary Cancer Care with emphasis on the following topics:  

• Rationale for a multidisciplinary cancer team

• Identifying and balancing the benefits and challenges of multidisciplinary team care

• Introducing the patient to the team concept and helping them navigate the team

• Maintaining the team under unique circumstances

• Applying the team concept inter-institutionally

• Managing holes in the team

• Surveillance management by the team